CQ HealthBeat News - Hatch May Soon Introduce Compromise Bill on Biotech Generics: "Sen. Orrin G. Hatch, R-Utah, said Wednesday that he is likely to introduce a bill soon aimed at striking a compromise on the issue of bringing generic versions of biotech drugs to market. But the move may not come in time for Senate floor action next week on a prescription drug bill (S 1082), widely viewed as must-pass legislation this year.
Speaking at a forum sponsored by the U.S. Chamber of Commerce, Hatch said he doesn’t expect generic biotech marketing provisions — whether written by him or other senators — to be part of S 1082. But he didn’t rule out the possibility, noting that congressional aides “literally have been working day and night” on the issue."
